ML0013

Glycolysis/Gluconeogenesis Metabolite Library

• UNSPSCコード: 41116107
• NACRES: NA.24

特性

• 保管温度: −20°C

詳細

構成

Contains 10 mg each of the glycolysis and gluconeogenesis pathway metabolite standards packaged individually.

その他情報

For additional information on our range of Biochemicals, please complete this form.

キットの構成要素は別途購入可能です。

• 158968 α-D-Glucose, anhydrous, 96% 15 mg
• B4501 Biotin, ≥99% (HPLC), lyophilized powder 10 mg
• D7137 Dihydroxyacetone phosphate dilithium salt, ≥93% dry basis (enzymatic) 10 mg
• F3627 D-Fructose 6-phosphate disodium salt hydrate, ≥98%, amorphous powder 10 mg
• F6803 D-Fructose 1,6-bisphosphate trisodium salt hydrate, ≥98% (TLC) 10 mg
• G6750 α-D-Glucose 1-phosphate dipotassium salt hydrate, ≥99% (HPLC), BioXtra 10 mg
• G7127 Guanosine 5′-diphosphate sodium salt, Type I, ≥96% (HPLC) 10 mg
G7528 D-(+)-Glucose, ≥99.5% (GC), BioXtra 10 mg
G7879 D-Glucose 6-phosphate sodium salt, ≥98% (HPLC) 10 mg
G8877 Guanosine 5′-triphosphate sodium salt hydrate, ≥95% (HPLC), powder 10 mg
K1750 α-Ketoglutaric acid, ≥98.5% (NaOH, titration) 10 mg
L1750 L-(+)-Lactic acid, ≥98% 10 mg
M8304 Malic acid, meets USP/NF testing specifications 10 mg
O7753 Oxaloacetic acid, powder, BioReagent, suitable for cell culture, suitable for insect cell culture, ≥97% (HPLC) 10 mg
P2256 Sodium pyruvate, ReagentPlus^®, ≥99% 15 mg
P7127 Phospho(enol)pyruvic acid monopotassium salt, ≥97% (enzymatic) 10 mg
P8877 D-(−)-3-Phosphoglyceric acid disodium salt, ≥93% dry basis (enzymatic), powder 10 mg

すべて表示 (17)

安全性情報

• ピクトグラム: GHS08,GHS05,GHS07
• シグナルワード: Danger
• 危険有害性情報: H314,H317,H335,H371
• 注意書き: P260 - P271 - P280 - P303 + P361 + P353 - P304 + P340 + P310 - P305 + P351 + P338
• 危険有害性の分類: Eye Dam. 1 - Skin Corr. 1C - Skin Sens. 1 - STOT SE 2 - STOT SE 3
• ターゲットの組織: Eyes,Central nervous system, Respiratory system
• 補足的ハザード: EUH071
• 保管分類コード: 8A - Combustible corrosive hazardous materials